vs
ExlService Holdings, Inc.（EXLS）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
ExlService Holdings, Inc.的季度营收约是Pediatrix Medical Group, Inc.的1.1倍（$542.6M vs $493.8M），ExlService Holdings, Inc.净利率更高（11.1% vs 6.8%，领先4.3%），ExlService Holdings, Inc.同比增速更快（12.7% vs -1.7%），过去两年ExlService Holdings, Inc.的营收复合增速更高（11.5% vs -0.1%）
ExlService Holdings Inc.是全球知名的分析与数字解决方案服务商，服务覆盖保险、医疗健康、银行金融服务、媒体、零售等多个行业，总部位于纽约，在美国、欧洲、亚洲、拉美、澳大利亚、南非等地拥有超过5.4万名专业从业人员。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
EXLS vs MD — 直观对比
营收规模更大
EXLS
是对方的1.1倍
$493.8M
营收增速更快
EXLS
高出14.4%
-1.7%
净利率更高
EXLS
高出4.3%
6.8%
两年增速更快
EXLS
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $542.6M | $493.8M |
| 净利润 | $60.2M | $33.7M |
| 毛利率 | 38.6% | — |
| 营业利润率 | 14.4% | 9.9% |
| 净利率 | 11.1% | 6.8% |
| 营收同比 | 12.7% | -1.7% |
| 净利润同比 | 18.9% | 10.5% |
| 每股收益（稀释后） | $0.38 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXLSMD
| Q4 25 | $542.6M | $493.8M | ||
| Q3 25 | $529.6M | $492.9M | ||
| Q2 25 | $514.5M | $468.8M | ||
| Q1 25 | $501.0M | $458.4M | ||
| Q4 24 | $481.4M | $502.4M | ||
| Q3 24 | $472.1M | $511.2M | ||
| Q2 24 | $448.4M | $504.3M | ||
| Q1 24 | $436.5M | $495.1M |
净利润EXLSMD
| Q4 25 | $60.2M | $33.7M | ||
| Q3 25 | $58.2M | $71.7M | ||
| Q2 25 | $66.1M | $39.3M | ||
| Q1 25 | $66.6M | $20.7M | ||
| Q4 24 | $50.7M | $30.5M | ||
| Q3 24 | $53.0M | $19.4M | ||
| Q2 24 | $45.8M | $-153.0M | ||
| Q1 24 | $48.8M | $4.0M |
毛利率EXLSMD
| Q4 25 | 38.6% | — | ||
| Q3 25 | 38.5% | — | ||
| Q2 25 | 37.7% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | 38.1% | — | ||
| Q3 24 | 37.8% | — | ||
| Q2 24 | 37.1% | — | ||
| Q1 24 | 37.4% | — |
营业利润率EXLSMD
| Q4 25 | 14.4% | 9.9% | ||
| Q3 25 | 14.4% | 13.8% | ||
| Q2 25 | 15.8% | 12.8% | ||
| Q1 25 | 15.7% | 7.0% | ||
| Q4 24 | 14.8% | 7.8% | ||
| Q3 24 | 14.7% | 6.6% | ||
| Q2 24 | 13.7% | -31.3% | ||
| Q1 24 | 14.1% | 3.2% |
净利率EXLSMD
| Q4 25 | 11.1% | 6.8% | ||
| Q3 25 | 11.0% | 14.5% | ||
| Q2 25 | 12.8% | 8.4% | ||
| Q1 25 | 13.3% | 4.5% | ||
| Q4 24 | 10.5% | 6.1% | ||
| Q3 24 | 11.2% | 3.8% | ||
| Q2 24 | 10.2% | -30.3% | ||
| Q1 24 | 11.2% | 0.8% |
每股收益（稀释后）EXLSMD
| Q4 25 | $0.38 | $0.40 | ||
| Q3 25 | $0.36 | $0.84 | ||
| Q2 25 | $0.40 | $0.46 | ||
| Q1 25 | $0.40 | $0.24 | ||
| Q4 24 | $0.31 | $0.37 | ||
| Q3 24 | $0.33 | $0.23 | ||
| Q2 24 | $0.28 | $-1.84 | ||
| Q1 24 | $0.29 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $328.4M | $375.2M |
| 总债务越低越好 | $298.6M | $570.5M |
| 股东权益账面价值 | $912.7M | $865.9M |
| 总资产 | $1.7B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.33× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资EXLSMD
| Q4 25 | $328.4M | $375.2M | ||
| Q3 25 | $390.1M | $340.1M | ||
| Q2 25 | $353.3M | $224.7M | ||
| Q1 25 | $331.4M | $99.0M | ||
| Q4 24 | $340.6M | $229.9M | ||
| Q3 24 | $325.8M | $103.8M | ||
| Q2 24 | $276.1M | $19.4M | ||
| Q1 24 | $246.2M | $8.0M |
总债务EXLSMD
| Q4 25 | $298.6M | $570.5M | ||
| Q3 25 | $354.8M | $577.2M | ||
| Q2 25 | $260.0M | $583.9M | ||
| Q1 25 | $307.3M | $590.5M | ||
| Q4 24 | $288.5M | $597.1M | ||
| Q3 24 | $344.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益EXLSMD
| Q4 25 | $912.7M | $865.9M | ||
| Q3 25 | $952.4M | $890.7M | ||
| Q2 25 | $1.1B | $833.8M | ||
| Q1 25 | $1.0B | $789.2M | ||
| Q4 24 | $929.9M | $764.9M | ||
| Q3 24 | $907.6M | $732.5M | ||
| Q2 24 | $852.6M | $706.5M | ||
| Q1 24 | $803.3M | $856.2M |
总资产EXLSMD
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.7B | $2.2B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $1.7B | $2.0B | ||
| Q4 24 | $1.6B | $2.2B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.4B | $2.2B |
负债/权益比EXLSMD
| Q4 25 | 0.33× | 0.66× | ||
| Q3 25 | 0.37× | 0.65× | ||
| Q2 25 | 0.25× | 0.70× | ||
| Q1 25 | 0.30× | 0.75× | ||
| Q4 24 | 0.31× | 0.78× | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $117.4M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $106.5M | — |
| 自由现金流率自由现金流/营收 | 19.6% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 1.95× | 3.39× |
| 过去12个月自由现金流最近4个季度 | $298.1M | — |
8季度趋势，按日历期对齐
经营现金流EXLSMD
| Q4 25 | $117.4M | $114.1M | ||
| Q3 25 | $120.7M | $137.3M | ||
| Q2 25 | $109.4M | $137.2M | ||
| Q1 25 | $3.2M | $-117.5M | ||
| Q4 24 | $105.3M | $133.0M | ||
| Q3 24 | $110.1M | $91.8M | ||
| Q2 24 | $74.9M | $107.0M | ||
| Q1 24 | $-21.9M | $-125.2M |
自由现金流EXLSMD
| Q4 25 | $106.5M | — | ||
| Q3 25 | $106.4M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $-9.7M | — | ||
| Q4 24 | $95.3M | — | ||
| Q3 24 | $97.3M | — | ||
| Q2 24 | $62.8M | — | ||
| Q1 24 | $-33.1M | — |
自由现金流率EXLSMD
| Q4 25 | 19.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.5% | — | ||
| Q1 25 | -1.9% | — | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.6% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | -7.6% | — |
资本支出强度EXLSMD
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.6% | — |
现金转化率EXLSMD
| Q4 25 | 1.95× | 3.39× | ||
| Q3 25 | 2.08× | 1.91× | ||
| Q2 25 | 1.66× | 3.49× | ||
| Q1 25 | 0.05× | -5.66× | ||
| Q4 24 | 2.08× | 4.36× | ||
| Q3 24 | 2.08× | 4.72× | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | -0.45× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
